Jasper Therapeutics, Inc. (JSPR, JSPRW)
2 SEC EDGAR filings indexed (CIK 0001788028) across 1 form type.
Filing profile
Jasper Therapeutics, Inc. (JSPR, JSPRW) has 2 SEC filings indexed on SecFilingDex, across 1 form type, from October 1, 2026 to October 5, 2026. The filer is classified under Biological Products (SIC 2836).
Its most frequent disclosure is the 8-K/A (Material event) with 2 filings — Current report announcing a material event, such as an acquisition, executive change, or earnings release. 2 of these filings were disclosed in the twelve months to October 5, 2026. 2 of the 2 are amendments (a corrected or updated version of an earlier filing).
Disclosure mix
- 28-K/AMaterial event · event-driven
Profile derived from 2 indexed filings; every figure traces to the filing records above, each linking back to its original SEC EDGAR document. Filing counts reflect SecFilingDex's current index, not the filer's complete EDGAR history.
All filings
Authoritative source
SecFilingDex republishes EDGAR data with provenance. EDGAR is authoritative; this page reflects the most recent index pull.
Disclaimer: SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page is investment, legal, or tax advice.